Skip to main content

Table 2 Distant gene fusions with multiple read support

From: Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples

Samples

Donor Gene (RefSeq)

Exon

5' chr

3' chr

Acceptor Gene (RefSeq)

Exon

Distance

Notes

Long distance

        

HBR(2)

IQCJ (NM_001042705)

4/5

+3

+3

SCHIP1 (NM_014575)

2/8

501759

5

N3(1), T2(5), T3(15)

TMPRSS2 (NM_005656)

1/14

-21

-21

ERG (NM_004449)

4/11

3062463

7

Scrambled exons

        

UHR(2)

RPS6KB1 (NM_003161)

4/15

+17

+17

TMEM49 (NM_030938)

12/12

74936

3,6

UHR(2)

GCN1L1 (NM_006836)

2/58

-12

-12

MSI1 (NM_002442)

12/15

157217

 

Inversions

        

UHR(7)

GAS6 (NM_000820)

12/15

+13

-13

RASA3 (NM_007368)

23/24

185397

6

UHR(2)

TGOLN2 (NM_006464)

3/4

-2

+2

USP39 (NM_006590)

11/13

320033

 

UHR(4)

ARFGEF2 (NM_006420)

1/39

+20

-20

SULF2 (NM_018837)

3/21

1172861

2,4,6

UHR(2)

LITAF (NM_001136472)

1/4

-16

+16

DECR2 (NM_020664)

2/9

11193286

 

N1(2)

REV1 (NM_016316)

3/23

-2

+2

CPSF3 (NM_016207)

10/18

89944295

 

Translocations

        

UHR(4)

BCAS4 (NM_017843)

1/6

+20

+17

BCAS3 (NM_017679)

23/24

 

3,4,6

UHR(3)

BCR (NM_004327)

14/23

+22

+9

ABL1 (NM_005157)

2/11

 

1,6

N1(2)

CAMTA1 (NM_015215)

3/23

+1

-12

SPPL3 (NM_139015)

3/11

  

UHR(2)

DYNC1H1 (NM_001376)

24/78

+14

+12

EIF4B (NM_001417)

8/15

  

T3(2)

MBTPS1 (NM_003791)

22/23

-16

+15

SERF2 (NM_001018108)

3/3

  

N2(2)

OGT (NM_181672)

6/22

+X

-5

RBM22 (NM_018047)

4/11

  

N1(2)

ROR2 (NM_004560)

1/9

-9

-17

USP36 (NM_025090)

2/20

  

T3(2)

SEC31A (NM_014933)

1/27

-4

-6

C6orf62 (NM_030939)

2/5

 

7

UHR(2)

TIMM9 (NM_012460)

3/6

-14

-8

PRKDC (NM_006904)

26/86

  

N1(2)

ZDHHC8 (NM_013373)

4/11

+22

+19

UBL5 (NM_024292)

3/5

  
  1. Each sample shows the number of supporting reads for the given fusion in parentheses. Exon values refer to the exon number and total number of exons in the given RefSeq transcript. Notes: (1) Known fusion in chronic myelogenous leukemia. (2) Observed in [53]. (3) Observed in [54]. (4) Observed in [55]. (5) Observed in [38]. (6) Observed in [17]. (7) Confirmed by PCR in this study.